Published in Hepatitis Weekly, August 20th, 2001
Scientists are conducting a controlled study of a new "artificial liver" that uses albumin, a protein that is produced naturally by the body and is a major component of human blood plasma, to remove toxins from the blood of patients in chronic liver failure who are comatose.
The new artificial liver is called a molecular adsorbent recirculation system, or MARS. With MARS, toxic substances in the blood bind to the albumin, cross into the dialysis solution, and are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.